#GVAP

[pinturas-sgm-aviacion]

1943 Petlyakov Pe-4 (Pe-2 M82)

Small series variant of Pe-2, with powerful ASh-82F engines. Aircraft emerged as a result of designer's efforts to improve flight performance of the aircraft. The aircraft was developed in the event there was a lack of engine M-105PF (VK-105PF), which have been preferably fitted to the fighters. Formed therefore, the provisions for spare engines M-82. This modified aircraft was in the spring of 1943 tested by the air force and was planned serial production. In the meantime,  the situation is reversed and while the engines M-105 was sufficient, the motors M-82 have become limited because they were used in the prototypes of the fighter aircraft such as the La-5 and La-7. It was therefore made in only 32 units, which in the years 1943 - 44 served in the 48. GvAP and in several special reconnaissance regiments.

[virologycomics-blog]

X VIRUS!

[aibagence]

Burkina : Les résultats des concours directs 2022 prévus pour fin novembre

Burkina : Les résultats des concours directs 2022 prévus pour fin novembre

Burkina-Administration-Concours-Résultats Burkina : Les résultats des concours directs 2022 prévus pour fin novembre Ouagadougou, 15 nov. 2022 (AIB)-Le secrétaire technique du guichet virtuel unique de l’administration publique (ST-GVAP), Aboubakary Sawadogo, a informé ce mardi, devant la presse, que tous les résultats des concours directs session 2022 seront prêts au plus tard en fin…

[sagarg889]

Pharmaceutical Container Market Segmentation and Analysis by Recent Trends, consumption by Regional data, Development, Investigation, Growth Forecast 2022-2032

The worldwide pharmaceutical container market is good to go to develop at a CAGR of 7.2% from US$ 90 Billion of every 2022 to US$ to US$ 180.38 Billion out of 2032.

This Pharmaceutical Container market concentrate on offers an exhaustive examination of the plans of action, key methodologies, and separate market portions of probably the most conspicuous players in this scene. Alongside a top to bottom discourse on the key affecting variables, market measurements with regards to incomes, portion wise information, district wise information, and country-wise information are presented in the full review.

This study is one of the most exhaustive documentation that catches every one of the aspects of the advancing Pharmaceutical Container market.

Pharmaceutical Container Market: Introduction

The scope and definition of pharmaceutical containers market includes revenue from packing materials used for protecting, storing, organizing, transporting of pharmaceutical products.

Pharmaceutical bottles are packaging systems specifically designed to meet the packaging requirements for pharmaceutical substances such as tablets, capsules, solutions & suspensions, sterile injectable and others, whereas vials are small containers that are mainly used to certify that patients take their dosage of drug in a precise quantity with timely manner. Plastic bottles and vials play vital role in growth of pharmaceutical container market globally.

Ease of storage, accurate dosing, and ease of disposal is driving the demand for pharmaceutical container market

Plastic bottle accounts for the significant share of the pharmaceutical container market due to the low cost, durability, and versatility. Plastic bottles are cheaper to produce, easier to replace, and convenient to transport to long distances, hence driving the demand of pharmaceutical container market.

Whereas vials ensure precise dosages which helps patients prefer self-administration of the medicine and are without any formal medical training. Owing to its manufacturing and formulation design, ampoules and vials can be stored easily due to its crack resistant covering/shield in which it is stored and transported.

Therefore escalating the need of pharmaceutical containers market. Technological advancement in the pharmaceutical industry will impact positively in the growth of pharmaceutical containers market.

Moreover, demand for parenteral is strongly correlated with immunization. Vaccination plans such as Global Vaccine Action Plan (GVAP) 2011–2020, National Vaccine Plan (NVP) by U.S., which are introduced by the government on regular intervals to eradicate health issues such as hepatitis, polio etc., are expected to further fuel the demand for parenteral packaging thus driving pharmaceutical containers market.

Tepid demand from complementary and alternative medicines can hamper the market growth

Complementary and alternative medicines is gaining wide prominence among users. Alternative treatment such as Homeopathy and Ayurveda has captured significant share in overall healthcare treatment market which can affect the pharmaceutical container market negatively. For instance,

As per the WHO estimates, ayurveda market was valued at US$ 118 Mn in 2015 and is forecast to grow at an average of 10% to 15% between 2015 and 2026.

Increasing alternative therapies could pose a challenge to overall pharmaceutical container market, especially in developing countries of Asia Pacific such as India and China. In addition to this, increasing counterfeiting of pharmaceutical products can impact on the growth of pharmaceutical container market.

Emerging Countries to play crucial role in the pharmaceutical containers market

Growing pharmaceutical industry in emerging countries such as Mexico, China and India accounts for healthy growth in the market. Most of the pharmaceutical companies have already started their production facilities in the China, India & Mexico which will create the enormous opportunities for the new entrants in the pharmaceutical container market.

Pharmaceutical Container Market: Key Players

Some of the key manufacturers in the pharmaceutical container market are as follows

SCHOTT AG

Alexander (James) Corporation

Amcor Limited

Berry Plastics

AptarGroup Incorporated

Gerresheimer Holdings GmbH

Becton, Dickinson and Company

Alpha Packaging

Emerging Countries to play crucial role in the pharmaceutical containers market

Growing pharmaceutical industry in emerging countries such as Mexico, China and India accounts for healthy growth in the market. Most of the pharmaceutical companies have already started their production facilities in the China, India & Mexico which will create the enormous opportunities for the new entrants in the pharmaceutical container market.

Pharmaceutical Container Market: Key Developments

US Alcan Packaging, Inc. has developed a plastic bottle in the pharmaceutical container segment, which consists of an implantable electronic identification code (RFID code). The code helps obtain information about the product such as manufacturer, production date, batch number, etc. at one swipe.

In October 2017, the company in collaboration with Xinkang started a new manufacturing facility in the China. The new plant will produce approximately two billion pieces of primary pharmaceutical containers made up of glass.

In April 2016, Becton, Dickinson and Company introduced Genesis—a low temperature rigid sterilization container.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, and inputs from industry experts and industry participants across the value chain of the global pharmaceutical container market. The report provides an in-depth analysis of parent market trends, macroeconomic indicators, and governing factors along with pharmaceutical container market attractiveness as per segments. The report also maps the qualitative impact of various factors on pharmaceutical container market segments and geographies.

For More Info - https://www.futuremarketinsights.com/reports/pharmaceutical-container-market 

[metiresearchinfo]

Vaccine Storage Equipment Market by Type (Electric Refrigerator, Solar Refrigerator, Ultra low temperature (ULT) Freezer, Consumables), End User (Hospitals and Medical Institutes, Distributors and Logistics) and Geography- Global Forecast to 2027

The Vaccine Storage Equipment Market is expected to grow at a CAGR of 10.6% from 2020 to reach $1.83 billion by 2027. Vaccines are extremely sensitive in nature and require to be kept at recommended temperature to maintain its efficiency. Purpose-built storage equipment, such as refrigerators and freezers, provides optimum cooling to the vaccines.

The growth in the vaccine storage equipment market is majorly propelled by large scale vaccination programs implemented by the global health agencies (such as WHO, UNICEF, GAVI (Global Alliance for Vaccines and Immunization), Vaccine for Children Program), high incidence of infectious diseases, launch of COVID-19 vaccines, among others. However, high cost of cold storage equipment and stringent vaccine storage requirements are expected to hinder the growth of the vaccine storage equipment market to some extent. In addition, development of highly stable and energy efficient ultra-low temperature freezers, and technology advancements serve as an opportunity for vendors in vaccine storage equipment market.

Launch of COVID-19 Vaccines

On March 11, 2020, the World Health Organization declared a global pandemic arising from corona virus disease – 19 (COVID-19). The pandemic triggered a race among leading drug-makers and research institutes to develop a vaccine at the earliest. On December 02, 2020, the U.K. approved covid-19 vaccines co-developed by Pfizer, Inc. (U.S.) and BioNTech. Since then, few other COVID-19 vaccines were approved for emergency use. Further, at least 7.7 billion vaccine doses have been purchased and another 3.9 billion reserved by varied countries and regions (Duke Global Health Innovation Center). These significant volume deliveries required in short duration is expected to create huge demand for vaccine storage equipment globally.

                                                        Click here to: Get Free Sample Pages of this Report

Implementation and on-going focus on the Global Vaccination Programs

A large number of vaccination programs are run by international organizations as well as local governments across the globe. These programs have created a significant network that manages vaccinations at large scale. Some of the leading global programs include The Global Vaccine Action plan (GVAP), Immunization Program by UNICEF, among others.

Key findings in the global vaccine storage equipment market study:

Freezers to register rapid growth during the forecast period

Freezer market is slated to grow at the fastest CAGR during the forecast period. freezers provide optimal storage temperature ranging from -15°C to -86°C for major vaccine types. Further, launch of Pfizer‘s and Moderna’s COVID-19 vaccines which requires -70°C to -86°C and -20°C is expected to provide tremendous growth to the ultra-low temperature freezer market in the next 2-3 years.

Distributor end user segment to witness rapid growth during the forecast period

Distributors segment is rapidly gaining traction and is expected to witness the highest growth, mainly attributed to the urgency and large-scale delivery requirement of COVID-19 vaccines across the globe.

North America: The fastest growing market

North America commanded the largest share of the global vaccine storage equipment market in 2020 and is expected to maintain its dominance throughout the forecast period. This region is also expected to grow at the highest growth during the forecast period. The large share of this region is mainly attributed to the U.S. and significant volume order placed by the U.S. and Canada for COVID-19 vaccine & vaccine storage equipment.

Key Players

Some of the key players operating in the global vaccine storage equipment market are Thermo Fisher Scientific, Inc. (U.S.), B Medical Systems (Luxembourg), Eppendorf AG (Germany), Cole-Parmer Instrumentation Company, LLC (U.S.), Haier Group Corporation (China), Philipp Kirsch GmbH (Germany), PHC Corporation (Japan), Helmer Scientific, Inc. (U.S.), EVERmed S.R.L. (Italy), and Vestfrost Solutions (Denmark), among others.

Scope of the Report:

Vaccine Storage Equipment Market, by Type                                          

Freezer

Refrigerator

Consumables & Accessories                                    

Ultra Low Temperature Freezer

Low Temperature Freezer

Upright Ultra Low Temperature Freezer

Chest Ultra Low Temperature Freezer

Upright Low Temperature Freezer

Chest Low Temperature Freezer

Electric

Solar

Others

Vaccine Storage Equipment Market, by End User                                              

Hospitals and Medical Institutes

Distributors

Others

Vaccine Storage Equipment Market, by Geography                              

North America

Europe

Asia-Pacific

Latin America

Middle East & Africa

U.S.

Canada

Germany

U.K.

France

Italy

Spain

Rest of Europe (RoE)

China

India

Japan

Rest of Asia-Pacific (RoAPAC)

[azzure-soul]

Gvap=good vibes and positivity

999

[rdouglasl]

Elevator to nowhere https://www.instagram.com/p/CUwaU7-gVaP/?utm_medium=tumblr

[virologycomics-blog]

Página #4_LAS INCREÍBLES AVENTURAS DE LOS VIRUS; VACUNAS #VacunasComics_pg_04

[sya-nda-ra]

#nature #pine #beach #sunlight #green #trees #outdoors #letsgosomewhere #goexplore #phonecam #zenfone3 #zenfonegraphy #zenfonecamera #zenfonegraphyindonesia #zenfonegraphy_indonesia #asuszenfonecamera https://www.instagram.com/p/Bkp6th-gvAP/?igshid=zxge7l9bs1b5

[metiresearchinfo]

Vaccine Storage Equipment Market by Type (Electric Refrigerator, Solar Refrigerator, Ultra low temperature (ULT) Freezer, Consumables), End User (Hospitals and Medical Institutes, Distributors and Logistics) and Geography- Global Forecast to 2027

The Vaccine Storage Equipment Market is expected to grow at a CAGR of 10.6% from 2020 to reach $1.83 billion by 2027. Vaccines are extremely sensitive in nature and require to be kept at recommended temperature to maintain its efficiency. Purpose-built storage equipment, such as refrigerators and freezers, provides optimum cooling to the vaccines.

The growth in the vaccine storage equipment market is majorly propelled by large scale vaccination programs implemented by the global health agencies (such as WHO, UNICEF, GAVI (Global Alliance for Vaccines and Immunization), Vaccine for Children Program), high incidence of infectious diseases, launch of COVID-19 vaccines, among others. However, high cost of cold storage equipment and stringent vaccine storage requirements are expected to hinder the growth of the vaccine storage equipment market to some extent. In addition, development of highly stable and energy efficient ultra-low temperature freezers, and technology advancements serve as an opportunity for vendors in vaccine storage equipment market.

Launch of COVID-19 Vaccines

On March 11, 2020, the World Health Organization declared a global pandemic arising from corona virus disease – 19 (COVID-19). The pandemic triggered a race among leading drug-makers and research institutes to develop a vaccine at the earliest. On December 02, 2020, the U.K. approved covid-19 vaccines co-developed by Pfizer, Inc. (U.S.) and BioNTech. Since then, few other COVID-19 vaccines were approved for emergency use. Further, at least 7.7 billion vaccine doses have been purchased and another 3.9 billion reserved by varied countries and regions (Duke Global Health Innovation Center). These significant volume deliveries required in short duration is expected to create huge demand for vaccine storage equipment globally.

                                                        Click here to: Get Free Sample Pages of this Report

Implementation and on-going focus on the Global Vaccination Programs

A large number of vaccination programs are run by international organizations as well as local governments across the globe. These programs have created a significant network that manages vaccinations at large scale. Some of the leading global programs include The Global Vaccine Action plan (GVAP), Immunization Program by UNICEF, among others.

Key findings in the global vaccine storage equipment market study:

Freezers to register rapid growth during the forecast period

Freezer market is slated to grow at the fastest CAGR during the forecast period. freezers provide optimal storage temperature ranging from -15°C to -86°C for major vaccine types. Further, launch of Pfizer‘s and Moderna’s COVID-19 vaccines which requires -70°C to -86°C and -20°C is expected to provide tremendous growth to the ultra-low temperature freezer market in the next 2-3 years.

Distributor end user segment to witness rapid growth during the forecast period

Distributors segment is rapidly gaining traction and is expected to witness the highest growth, mainly attributed to the urgency and large-scale delivery requirement of COVID-19 vaccines across the globe.

North America: The fastest growing market

North America commanded the largest share of the global vaccine storage equipment market in 2020 and is expected to maintain its dominance throughout the forecast period. This region is also expected to grow at the highest growth during the forecast period. The large share of this region is mainly attributed to the U.S. and significant volume order placed by the U.S. and Canada for COVID-19 vaccine & vaccine storage equipment.

Key Players

Some of the key players operating in the global vaccine storage equipment market are Thermo Fisher Scientific, Inc. (U.S.), B Medical Systems (Luxembourg), Eppendorf AG (Germany), Cole-Parmer Instrumentation Company, LLC (U.S.), Haier Group Corporation (China), Philipp Kirsch GmbH (Germany), PHC Corporation (Japan), Helmer Scientific, Inc. (U.S.), EVERmed S.R.L. (Italy), and Vestfrost Solutions (Denmark), among others.

Scope of the Report:

Vaccine Storage Equipment Market, by Type                                          

Freezer

Refrigerator

Consumables & Accessories                                    

Ultra Low Temperature Freezer

Low Temperature Freezer

Upright Ultra Low Temperature Freezer

Chest Ultra Low Temperature Freezer

Upright Low Temperature Freezer

Chest Low Temperature Freezer

Electric

Solar

Others

Vaccine Storage Equipment Market, by End User                                              

Hospitals and Medical Institutes

Distributors

Others

Vaccine Storage Equipment Market, by Geography                              

North America

Europe

Asia-Pacific

Latin America

Middle East & Africa

U.S.

Canada

Germany

U.K.

France

Italy

Spain

Rest of Europe (RoE)

China

India

Japan

Rest of Asia-Pacific (RoAPAC)

[just-cruisin]

Day 13. Fitness Training under 1 hour. (at Planet Fitness) https://www.instagram.com/p/B7R81Q-gvaP/?igshid=p1hgy5rkdqqk

[muabannhadatquan12]

NHÀ GIÁ RẺ 1 Trệt 1 Lầu 2PN 2wc Hà Huy Giáp Q12. Giá: 1.195 Tỷ

NHÀ GIÁ RẺ 1 Trệt 1 Lầu 2PN 2wc Hà Huy Giáp Q12. Giá: 1.195 Tỷ Cần Tiền Bán Gấp Nhà Chứ K cho Thuê Sợ Hư Nhà Còn Quá Mới Thơm Mùi Sơn Thơm Phức. **Mô Tả: Dt. 3,7m x 8m. Nhà 1 Trệt 1 Lầu 2 Pn, 2 Tollet. Rộng Rãi thoải mái, gđinh ở 6 người cũng được. TẶNG NỘI THẤT CHĂN RÈM TỦ ĐẦY ĐỦ ** Nhà Tường riêng, Đúc Thật, ép cọc kiến cố vững chắc 100%, thiết kế dây ga máy lạnh âm chờ. ** Vị Trí/ Tiện ích: Nằm Trên Trục Đường Hà Huy Giáp thuận tiện về Gvap, Binh Thạnh, về Trung Tâm Tp chỉ 20p xe máy, về Bình Dương cũng dễ dàng. Hẻm vô Nhà 6m oto thoải mái, khu an ninh dân trí cao toàn nhà lầu ** Đồng hồ điện riêng, nước máy thủy cục giá nhà nước. Hệ Thống cống rảnh thoát nước hiện đại. Không ngập nước. ** Pháp Lý: Sổ Hồng con Đứng Tên Từng căn * GIÁ RẺ: 1.195 ty quá rẻ so với khu vực này rồi. Hướng Tây, Nam,Bắc đều có nha A/chị. * L/Hệ: Vũ ZALO . Hiện Tại Vũ còn hơn 150 căn nhà giá tầm 600tr đến 2,4tỷ có sổ hồng rõ ràng giấy tờ quy hoạch sạch sẽ. A chị xem còn đi xét lại nữa nên yên tâm mua nhà ở nha. Hi. ANH CHỊ Hãy tham quan và so sánh đảm bảo sẽ thích ngay. Hihi :B :B :B

#MuabannhadatQuan12 #NhadatCafeland source https://nhadat.cafeland.vn/nha-gia-re-1-tret-1-lau-2pn-2wc-ha-huy-giap-q12-gia-1195-ty-1194309.html

[muabannhadatgovap]

RẺ VÔ ĐỊCH nhà Quang Trung G.Vấp 64m2 DTSD gần Vincom chỉ 2.55 tỷ

SALE MẠNH NHƯ SHOPEE - GIÁ GIẢM CÒN 2.55 tỷ (GỐC 3 tỷ) Quang Trung phường 10 Gò Vấp Diện tích sử dụng: 64m2 , 3.5mx9m x 2 tầng Mô tả: + Nhà kết cấu: 1 trệt, 1 lầu, ban công gồm 2 phòng ngũ, 2WC, 2phòng bếp, phòng khách + Nhà lô góc, 2 mặt hẻm xe hơi, sạch đẹp, thoáng mát. + Khu vưc dân trí cao, dân cư đông đúc, sát sân bay, tiện ích xung quanh không thiếu thứ gì, tiện di chuyển khắp nẻo. + Sổ hồng chính chủ , pháp lý chuẩn, công chứng trong ngày. Alo liền cho Hải Gò Vấp

#MuabannhadatQuanGoVap #NhadatCafeland source https://nhadat.cafeland.vn/re-vo-dich-nha-quang-trung-gvap-64m2-dtsd-gan-vincom-chi-255-ty-1977061.html

[herwitchinesss]

the best part of waking up is snail mucus on yr face (& cats & books but my face is so soooooft so yknow 🤷🏼‍♀️) obviously, I’m on an Asian countries inspired YA fantasy kick- I can’t believe there’s so many I’ve not read yet 😱 but also excited bc it means I get to read them now! #bookstagram #booklr #audible #audiobooks #reading #skincare #nomakeup #nofilter #nails #catsofinstagram #catstagram https://www.instagram.com/p/B0ONGQ-gvap/?igshid=1bsfxjxe8ajgt

[pawarsaagar-blog]

Measles And Rubella Vaccines Market to Reflect Impressive Growth Rate During 2018 to 2026

Measles-rubella (MR) vaccines have a strong contribution to the reduction of under-five child death and disability. Various government organizations such as Pan American Health Organization and UNICEF are focusing on conduct campaign are initiatives to prevent measles-rubella. In 2015, The Pan American Health Organization of the World Health Organization declared that the Americans regions are the world’s first region to remove rubella and congenital rubella syndrome by vaccination. But, rubella and measles are quite common in other parts of the world. People can become infect in other countries and bring it home. Various countries government and organizations are conducted prevention programs which expected to favors the growth of the measles-rubella (MR) vaccines market. In 2012, World Health Assembly declared Global Vaccine Action Plan (GVAP) to eliminate measles, rubella, and CRS by 2020 in Five WHO regions. Measles-rubella (MR) vaccines initiatives are run by the American Red Cross, WHO, UNICEF, United Nation Children’s Foundation, and U.S. Centers for Disease Control and Prevention.

Request For Sample Report-https://bit.ly/2Qq8zE5

Rising government and non-government funding for MR vaccine development, and the high prevalence of diseases are the major driving factor of measles-rubella (MR) vaccines market. Increasing investment by companies and growing immunization programs expected to propel the growth of measles-rubella (MR) vaccines market. Increasing global vaccination coverage expected to favor the growth of measles-rubella (MR) vaccines market. Coverage of measles-rubella (MR) vaccines increased from 22% in 2000 to 46% in 2015 globally. Increasing demand for measles-rubella (MR) vaccines expected to propel the growth of the measles-rubella (MR) vaccines market. In 2014, UNICEF estimated requirement of measles vaccines could reach up to 190 Mn doses. Partnership with government organizations and manufactures to meet the demand of measles-rubella (MR) vaccines expected to impel the growth of measles-rubella (MR) vaccines market.

The global measles-rubella (MR) vaccines market is segmented on basis of product type, age group, distribution channel, and region:

Segmentation by Product Type

Segmentation by Age Group

Segmentation by Distribution Channel

Monovalent Vaccines

Multivalent Vaccines

Pediatric

Adult

Hospitals & Clinics

Hospital Pharmacies

Retail Pharmacies

Community Clinics

Request For TOC-https://bit.ly/2W5UFNH

Measles-rubella (MR) vaccines market expected to represent a significant growth rate over the forecast period. Increasing government immunization programs manufactures supports to provide cost-effective vaccines expected to favors the growth of the Measles-rubella (MR) vaccines market. Monovalent vaccine expected to gain high share in the Measles-rubella (MR) vaccines market over the forecast period.

Regionally, the global measles-rubella (MR) vaccines market is segmented into five key regions viz. North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America is expected to lead the global measles-rubella (MR) vaccines market owing to high awareness regarding infectious diseases and increasing healthcare expenditure. Europe also shows the second largest market in the measles-rubella (MR) vaccines market due to the increasing government vaccination programs and growing investments in vaccination. The measles-rubella (MR) vaccines market in the Asia-Pacific region is expected to witness significant growth rate in the coming years due to increasing healthcare expenditure, government initiatives, increasing per capita income. The government is expanding vaccination programs to increase prevention from infectious diseases. In 2013, South-East Asia regional committee fixed the goal for the elimination of measles and rubella by 2020.

Some of the players operating in the global measles-rubella (MR) vaccines market are Serum Institute of India Ltd., Merck & Co. Inc., GlaxoSmithKline Inc., Takeda Pharmaceutical Company, and others. Companies are focusing on research and development of vaccines for prevention from measles and rubella.

The report covers exhaustive analysis on:

Measles-rubella (MR) vaccines Market Segments

Measles-rubella (MR) vaccines Market Dynamics

Historical Actual Market Size, 2013 - 2017

Measles-rubella (MR) vaccines Market Size & Forecast 2018 to 2026

Measles-rubella (MR) vaccines Market Current Trends/Issues/Challenges

Competition & Companies involved

Measles-rubella (MR) vaccines Market Drivers and Restraints

[hogbu]

GVAP

Tom - Flickr